Tempest Therapeutics, Inc.
TPST
$6.87
$0.385.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -84.47% | -55.56% | -26.24% | -3.51% | 17.74% |
| Total Depreciation and Amortization | -42.35% | 10.23% | 86.75% | -29.60% | -60.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.39% | 58.97% | 92.87% | 93.88% | 79.13% |
| Change in Net Operating Assets | 675.80% | -66.10% | 940.67% | 31.80% | -122.42% |
| Cash from Operations | -64.36% | -56.96% | 13.80% | 13.45% | 4.69% |
| Capital Expenditure | 57.14% | -- | -112.82% | -265.22% | 98.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 57.14% | -- | -112.82% | -265.22% | 98.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -41.33% | 17,709.52% | 283.59% | 922.73% | 286,141.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.74% | 7,238.10% | 283.59% | 922.73% | 826.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.31% | -33.87% | 77.41% | 16.87% | 343.64% |